z-logo
open-access-imgOpen Access
Experience using propranolol for the management of supraventricular tachycardia in patients younger than 1 year
Author(s) -
Eliaicastro,
María G. Majdalani,
Mauricio Abelló,
David Doiny,
Estela Falconi,
Carlos JerjesSánchez,
José M. Moltedo
Publication year - 2020
Publication title -
archivos argentinos de pediatria
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.236
H-Index - 19
eISSN - 1668-3501
pISSN - 0325-0075
DOI - 10.5546/aap.2020.eng.273
Subject(s) - medicine , supraventricular tachycardia , propranolol , adverse effect , supraventricular arrhythmia , heart disease , tachycardia , ventricular tachycardia , cardiology , anesthesia , population , atrial fibrillation , environmental health
To assess the results and adverse events of propranolol therapy in infants younger than 1 year with supraventricular tachycardia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom